PulsePoint, a specialist in healthcare advertising technology, announced on June 23, 2026 that it is rolling out a feature called Ad Server Creative ID Reporting. The tool bridges the gap between creative identifiers stored in major ad‑server platforms—such as Google Campaign Manager 360—and the individual physician (NPI) data that PulsePoint aggregates. By marrying these two data silos, the company claims marketers can now pinpoint which rotating creative performed best for each health‑care professional, and adjust their omnichannel strategies accordingly.
Why the integration matters
Healthcare marketers have long grappled with a disconnect: ad‑servers excel at tracking which creative was shown, but they seldom tie that information to the specific clinician who saw it. Conversely, platforms that profile physicians can identify who engaged with a campaign but lack visibility into the exact message that prompted the interaction. PulsePoint’s new capability purports to solve that mismatch, delivering what the vendor describes as “true granular visibility” into creative performance at the NPI level.
The practical upshot is a more data‑driven approach to personalization. Rather than making assumptions about which message resonates with a particular segment, brands can now observe, on a per‑physician basis, which creative variant drove the desired action—be it a click, video view, or form submission. In theory, this should reduce reliance on broad‑brush testing and enable faster, more precise optimization across channels such as display, video, and native placements.
How the feature works
At its core, Creative ID Reporting automatically extracts the unique creative identifiers that ad‑servers assign to each impression. Those IDs are then stitched to PulsePoint’s existing physician‑level data set, which already includes behavioral signals across a range of digital touch‑points. The result is a single reporting view where marketers can filter or segment by both channel and creative, seeing not only the volume of engagements but also the specific message that generated them.
Because the data flow is built into PulsePoint’s Report Builder, users do not need to configure new pipelines or learn additional tools. The new dimension can be added to any existing report template, and scheduled deliveries continue to operate as before. PulsePoint emphasizes that the integration does not introduce extra manual steps, a point that resonates with agencies accustomed to juggling multiple platforms.
Early adopters weigh in
The feature was piloted with two notable partners: Butler/Till, a health‑care marketing agency, and Salix Pharmaceuticals, a specialty drug maker. Both firms were selected for their sophisticated, multi‑creative campaigns that rotate several messages within the same ad placement.
“Traditional campaign constructs did not allow us to deploy message journeys. Now we are able to both align our segment messaging and consider next best action at the provider level,” said Christine Tucco, Director of Digital Strategy at Salix Pharmaceuticals. “We saw an opportunity to solve a clear gap in executing true omnichannel personalization, so we partnered early to help shape the solution. I would tell others that if they are serious about providing the right message in the right channel, leaning in early to innovations like this is critical.”
Butler/Till’s senior planner echoed the sentiment, highlighting operational efficiencies:
“Getting visibility into which creative messages HCPs were being served was essential to fueling our client’s omnichannel strategy, but achieving it the way we knew how would have disrupted our trafficking processes and conflicted with ad‑serving best practices. When we shared that challenge with PulsePoint, they didn’t just listen. They solved it,” said Danielle Fox, Senior Integrated Planning Director at Butler/Till. “After iterating together to get it right, the resulting solution was easy to implement, saved us from quadrupling our trafficking needs, and gave us the content intelligence our client’s strategy demanded.”
Technical perspective from PulsePoint
PulsePoint’s chief product officer, Ezra Suveyke, framed the launch as a response to the increasing complexity of modern health‑care campaigns:
“Our clients are running campaigns of real sophistication with multiple creatives, multiple segments, multiple channels, and multiple platforms. Ad Server Creative ID Reporting is about interoperability and bringing the signals that live in ad servers like CM360 into PulsePoint’s physician‑level data environment,” he explained. “Marketers get the creative‑level NPI attribution to match the complexity of how they’re actually running omnichannel campaigns and they get it without the manual lift that used to make that kind of insight cumbersome.”
Suveyke’s comments hint at a broader strategic direction: positioning PulsePoint as a unifying layer that can ingest signals from disparate ad‑tech stacks while preserving the granularity required for health‑care compliance and measurement.
Industry context
The health‑care advertising landscape has been evolving rapidly, driven by stricter privacy regulations, the rise of programmatic buying, and the growing importance of physician‑centric digital experiences. Traditional media planning tools often fall short when it comes to linking a specific creative to a specific clinician, especially when campaigns span multiple programmatic channels.
Competitors such as Adobe Advertising Cloud, The Trade Desk, and MediaMath have introduced creative‑level reporting modules, but they generally focus on aggregate performance metrics rather than physician‑level attribution. PulsePoint’s claim to deliver NPI‑specific insight sets it apart, at least on paper, and could push other vendors to enhance their own data‑linking capabilities.
Moreover, the ability to combine creative performance with PulsePoint’s existing behavioral data (e.g., content consumption, search activity) may enable more sophisticated predictive models. Brands could, for instance, forecast which message variant is likely to move a particular physician toward a prescription decision, and allocate budget in real time.
Potential challenges and considerations
- Data privacy and compliance – Linking creative IDs to NPI data raises questions about HIPAA and other privacy frameworks. PulsePoint will need to demonstrate robust de‑identification and consent mechanisms to satisfy regulators and health‑care providers.
- Ad‑server compatibility – The announcement mentions Google Campaign Manager 360, but many agencies also rely on other platforms like Amazon Advertising, Meta Business Suite, or custom demand‑side platforms. Extending the integration beyond CM360 will be essential for broader market penetration.
- Measurement validation – Marketers will want independent verification that the stitched data accurately reflects what each physician saw. Third‑party audits or industry certifications could become a prerequisite for large pharma spenders.
- Learning curve – Even though PulsePoint claims the feature integrates seamlessly into existing reporting workflows, analysts will need to understand how to interpret the new creative‑ID dimension and incorporate it into optimization algorithms.
Business impact
If the solution delivers on its promises, health‑care advertisers could see several tangible benefits:
- Higher ROI – By identifying the most effective creative for each physician, brands can allocate spend toward the variants that drive the greatest conversion, reducing waste.
- Faster iteration – Real‑time visibility into creative performance may shorten the testing cycle, allowing teams to pivot quickly in response to market dynamics.
- Enhanced personalization – Granular data supports more nuanced message sequencing, moving beyond static segmentation toward dynamic, physician‑specific journeys.
- Operational efficiency – Automating the data merge eliminates manual spreadsheets and reduces the risk of human error, a point emphasized by Butler/Till’s senior planner.
For agencies, the feature could become a differentiator when pitching to pharma clients, offering a measurable path to omnichannel personalization that has historically been elusive.
Outlook
PulsePoint’s Creative ID Reporting arrives at a moment when health‑care marketers are under pressure to demonstrate measurable outcomes while navigating a fragmented digital ecosystem. The move reflects a broader industry trend toward data unification—bringing together first‑party signals, third‑party ad‑tech data, and domain‑specific identifiers to create a single source of truth.
Whether the tool becomes a standard part of the health‑tech marketer’s toolkit will depend on its scalability, compliance posture, and the degree to which other ad‑tech providers respond with comparable capabilities. For now, the announcement signals that the gap between creative performance and physician‑level attribution is narrowing, and that health‑care brands are willing to invest in the technology needed to close it.
Get in touch with our Adtech experts
